Squarepoint Ops LLC Buys New Position in AngioDynamics, Inc. (NASDAQ:ANGO)

Squarepoint Ops LLC bought a new position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 42,258 shares of the medical instruments supplier's stock, valued at approximately $387,000. Squarepoint Ops LLC owned approximately 0.10% of AngioDynamics at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Divisadero Street Capital Management LP bought a new position in AngioDynamics during the fourth quarter valued at about $4,714,000. Segall Bryant & Hamill LLC grew its position in AngioDynamics by 55.3% during the fourth quarter. Segall Bryant & Hamill LLC now owns 1,415,156 shares of the medical instruments supplier's stock valued at $12,963,000 after buying an additional 503,713 shares during the period. Marshall Wace LLP grew its position in AngioDynamics by 1,335.1% during the fourth quarter. Marshall Wace LLP now owns 476,824 shares of the medical instruments supplier's stock valued at $4,368,000 after buying an additional 443,598 shares during the period. Nuveen Asset Management LLC grew its position in AngioDynamics by 37.4% during the fourth quarter. Nuveen Asset Management LLC now owns 1,296,366 shares of the medical instruments supplier's stock valued at $11,875,000 after buying an additional 353,070 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its position in AngioDynamics by 293.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 352,544 shares of the medical instruments supplier's stock valued at $3,229,000 after buying an additional 263,034 shares during the period. Institutional investors own 89.43% of the company's stock.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a "buy" rating and set a $16.00 target price (up previously from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

AngioDynamics Price Performance

NASDAQ:ANGO traded up $0.10 on Friday, reaching $11.06. 765,700 shares of the company's stock were exchanged, compared to its average volume of 573,299. The firm has a market cap of $449.11 million, a price-to-earnings ratio of -1.96 and a beta of 0.62. AngioDynamics, Inc. has a 52 week low of $5.47 and a 52 week high of $13.50. The stock has a fifty day simple moving average of $9.58 and a 200-day simple moving average of $9.70.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last announced its quarterly earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The firm had revenue of $72.00 million for the quarter, compared to the consensus estimate of $70.30 million. The firm's revenue was down 4.3% on a year-over-year basis. As a group, sell-side analysts predict that AngioDynamics, Inc. will post -0.37 EPS for the current year.

AngioDynamics Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.